Region specific distribution of levomepromazine in the human brain

Journal of Neural Transmission

Volumn 113, Issue 3, 2006, Pages 387-397

  Kornhuber, J ^a   Weigmann, H ^b   Rohrich J ^b   Wiltfang, J ^a   Bleich, S ^a   Meineke, I ^c   Zochling R ^d   Hartter S ^b   Riederer, P ^e   Hiemke, C ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d Lower Austria LKH for Psychiatry   (Austria)

^e UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Human; Levomepromazine; Neuroleptic drug; Pharmacokinetics; Postmortem brain; Region specific distribution

Indexed keywords

DRUG METABOLITE; LEVOMEPROMAZINE; NORLEVOMEPROMAZINE; UNCLASSIFIED DRUG;

AGED; ANALYSIS OF VARIANCE; ARTICLE; BASAL GANGLION; BRAIN CORTEX; BRAIN REGION; BRAIN TISSUE; CADAVER; CALCULATION; CEREBELLUM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEATH; DOSE RESPONSE; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG STRUCTURE; DRUG TISSUE LEVEL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; KINETICS; LIMBIC SYSTEM; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; THALAMUS; TIME;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA; BRAIN; CYTOCHROME P-450 CYP2D6; FEMALE; HUMANS; MALE; METABOLIC CLEARANCE RATE; METHOTRIMEPRAZINE; MOLECULAR STRUCTURE;

EID: 32044434685     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-005-0331-3     Document Type: Article

References (49)

1. A-HM Afifi EL Way 1967 Estimation of methotrimeprazine in brain and correlation of brain levels with pharmacologic activity. J Pharm Sci 56 720 724
2. A-HM Afifi EL Way 1968 Studies on the biologic disposition of methotrimeprazine. J Pharmacol Exp Ther 160 397 406
3. R) in man. Acta Psychiatr Neurol Scand [Suppl 39] [Suppl 169]: 366-381
4. C Andersson RM Hamer CP Lawler RB Mailman JA Lieberman 2002 Striatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs. Neuropsychopharmacology 27 143 151
5. A Bal M Smialowska 1987 The influence of some antidepressant drugs on the nuclear volume of rat cingulate cortex cells in culture. Neuroscience 22 671 674
6. A Bal-Klara MM Bird 1990 The effects of various antidepressant drugs on the fine-structure of neurons of the cingulate cortex in culture. Neuroscience 37 685 692
7. Beal SL, Sheiner LB (1992) NONMEM Users Guides, NONMEM Project Group, San Francisco. University of California, San Francisco
8. MR Britto PJ Wedlund 1992 Cytochrome P-450 in the brain. Potential evolutionary and therapeutic relevance of localization of drug-metabolizing enzymes. Drug Metab Dispos 20 446 450
9. MH Chakos JA Liebermann J Alvir RM Bilder M Ashtari 1995 Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine. Lancet 345 456 457
10. MH Chakos O Shirakawa J Lieberman H Lee R Bilder CA Tamminga 1998 Striatal enlargement in rats chronically treated with neuroleptic. Biol Psychiatry 44 675 684
11. BM Cohen S Babb A Campbell RJ Baldessarini 1988 Persistence of haloperidol in the brain. Arch Gen Psychiatry 45 879 880
12. PW Corson P Nopoulos DD Miller S Arndt NC Andreasen 1999 Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. Am J Psychiatry 156 1200 1204
13. SG Dahl 1976 Pharmacokinetics of methotrimeprazine after single and multiple doses. Clin Pharmacol Ther 19 435 442
14. SG Dahl 1982 Active metabolites of neuroleptic drugs: possible contribution to therapeutic and toxic effects. Ther Drug Monit 4 33 40
15. SG Dahl M Garle 1977 Identification of nonpolar methotrimeprazine metabolites in plasma and urine by GLC-mass spectrometry. J Pharm Sci 66 190 193
16. SG Dahl H Johnsen CR Lee 1982 Gas chromatographic mass spectrometric identification of O-demethylated and mono-hydroxylated metabolites of levomepromazine in blood from psychiatric patients by selected ion recording with high resolution. Biomed Mass Spectrometry 9 534 538
17. SG Dahl RE Strandjord S Sigfusson 1977 Pharmacokinetics and relative bioavailability of levomepromazine after repeated administration of tablets and syrup. Eur J Clin Pharmacol 11 305 310
18. WA Daniel 2003 Mechanisms of cellular distribution of psychotropic drugs. Significance for drug action and interactions. Prog Neuropsychopharmacol Biol Psychiatry 27 65 73
19. WA Daniel J Wójcikowski 1997 Contribution of lysosomal trapping to the total tissue uptake of psychotropic drugs. Pharmacol Toxicol 80 62 68
20. WA Daniel J Wojcikowski A Palucha 2001 Intracellular distribution of psychotropic drugs in the grey and white matter of the brain: the role of lysosomal trapping. Br J Pharmacol 134 807 814
21. PM Doraiswamy LA Tupler KR Krishnan 1995 Neuroleptic treatment and caudate plasticity [published erratum appears in Lancet (1995) 345(8959): 1250]. Lancet 345 734 735
22. AA El Ela S Härtter U Schmitt C Hiemke H Spahn-Langguth P Langguth 2004 Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds - implications for pharmacokinetics of selected substrates. J Pharm Pharmacol 56 967 975
23. W Gsell KW Lange R Pfeuffer S Heckers H Heinsen D Senitz K Jellinger G Ransmayr I Wichart R Vock H Beckmann P Riederer 1993 How to run a brain bank. A report from the Austro-German brain bank. J Neural Transm [Suppl] 39 31 70
24. LM Gunne JE Haggstrom B Sjoquist 1984 Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis. Nature 309 347 349
25. RE Gur V Maany PD Mozley C Swanson W Bilker RC Gur 1998 Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. Am J Psychiatry 155 1711 1717
26. PA Hals SG Dahl 1994 Effect of levomepromazine and metabolites on debrisoquine hydroxylation in the rat. Pharmacol Toxicol 75 255 260
27. + pump) underlying volume regulation in corneal endothelial cells. J Membr Biol 171 75 85
28. S Heckers H Heinsen Y Heinsen H Beckmann 1991 Cortex, white matter, and basal ganglia in schizophrenia: a volumetric postmortem study. Biol Psychiatry 29 556 566
29. T Hilberg J Mørland A Bjørneboe 1994 Postmortem release of amitriptyline from the lungs; a mechanism of postmortem drug redistribution. Forensic Sci Int 64 47 55
30. EK Hoffmann LO Simonsen 1989 Membrane mechanisms in volume and pH regulation in vertebrate cells. Physiol Rev 69 315 382
31. PAJ Janssen W Soudijn I Wijngaarden A Dresse 1968 Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. III. Regional distribution of pimozide and of haloperidol in the dog brain. Arzneimittelforschung 18 282 287
32. H Johnsen SG Dahl 1982 Identification of O-demethylated and ring-hydroxylated metabolites of methotrimeprazine (levomepromazine) in man. Drug Metab Dispos 10 63 67
33. J Kornhuber W Retz P Riederer 1995 Slow accumulation of psychotropic substances in the human brain. Relationship to therapeutic latency of neuroleptic and antidepressant drugs? J Neural Transm [Suppl] 46 311 319
34. J Kornhuber A Schultz J Wiltfang I Meineke CH Gleiter R Zöchling K-W Boissl F Leblhuber P Riederer 1999 Persistence of haloperidol in human brain tissue. Am J Psychiatry 156 885 890
35. ER Korpi JE Kleinman DT Costakos M Linnoila RJ Wyatt 1984 Reduced haloperidol in the post-mortem brains of haloperidol-treated patients. Psychiatry Res 11 259 269
36. PM Laduron PF Janssen JE Leysen 1978 Spiperone: a ligand of choice for neuroleptic receptors. 2. Regional distribution and in vivo displacement of neuroleptic drugs. Biochem Pharmacol 27 317 321
37. Martindale. The Extra Pharmacapoeia (1993). In: Reynolds JEF (ed) The Pharmaceutical Press, London, pp xxi-xxv
38. UA Meyer R Amrein LP Balant L Bertilsson M Eichelbaum TW Guentert S Henauer P Jackson G Laux H Mikkelsen C Peck BG Pollock R Priest F Sjöqvist A Delini-Stula 1996 Antidepressants and drug-metabolizing enzymes - expert group report. Acta Psychiatr Scand 93 71 79
39. DD Miller NC Andreasen DS O'Leary K Rezai GL Watkins LL Ponto RD Hichwa 1997a Effect of antipsychotics on regional cerebral blood flow measured with positron emission tomography [published erratum appears in Neuropsychopharmacology (1998) 18(4): 323-324]. Neuropsychopharmacology 17 230 240
40. DD Miller K Rezai R Alliger NC Andreasen 1997b The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia: assessment with technetium-99∈m hexamethyl-propyleneamine oxime single photon emission computed tomography. Biol Psychiatry 41 550 559
41. E Morel KG Lloyd SG Dahl 1987 Anti-apomorphine effects of phenothiazine drug metabolites. Psychopharmacology Berl 92 68 72
42. PJ Norris JP Hardwick PC Emson 1996 Regional distribution of cytochrome P450 2D1 in the rat central nervous system. J Comp Neurol 366 244 258
43. V Ravindranath S Bhamre SV Bhagwat HK Anandatheerthavarada SK Shankar PS Tirumalai 1995 Xenobiotic metabolism in brain. Toxicol Lett 82-83 633 638
44. B Schilter CJ Omiecinski 1993 Regional distribution and expression modulation of cytochrome P-450 and epoxide hydrolase mRNAs in the rat brain. Mol Pharmacol 44 990 996
45. OZ Sellinger RA Hiatt 1968 Cerebral lysosomes. IV. The regional and intracellular distribution of arylsulfatase and evidence for two populations of lysosomes in rat brain. Brain Res 7 191 200
46. L Sklair-Tavron WX Shi SB Lane HW Harris BS Bunney EJ Nestler 1996 Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc Natl Acad Sci USA 93 11202 11207
47. T Sunderland BM Cohen 1987 Blood to brain distribution of neuroleptics. Psychiatry Res 20 299 305
48. H Tokunaga K Kudo T Imamura N Jitsufuchi Y Ohtsuka N Ikeda 1997 Plasma concentrations of antipsychotic drugs in psychiatric inpatients. Nippon Hoigaku Zasshi 51 417 422
49. H Weigmann S Härtter C Hiemke 1998 Automated determination of clomipramine and its major metabolites in human and rat serum by high-performance liquid chromatography with on-line column-switching. J Chromatogr B Biomed Sci Appl 710 227 233